HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bradley A Schulte Selected Research

Bradley A Schulte Research Topics

Disease

9Neoplasms (Cancer)
01/2021 - 01/2006
4Lung Neoplasms (Lung Cancer)
09/2017 - 01/2013
2Triple Negative Breast Neoplasms
01/2021 - 12/2017
1Breast Neoplasms (Breast Cancer)
01/2019
1Hearing Loss (Hearing Impairment)
01/2018
1Demyelinating Diseases (Demyelinating Disease)
01/2018
1Neoplasm Metastasis (Metastasis)
12/2017
1Residual Neoplasm
12/2017
1Carcinogenesis
09/2017
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
09/2017
1Auditory neuropathy
06/2008
1Noise-Induced Hearing Loss (Acoustic Trauma)
03/2006
1Bartter Syndrome (Syndrome, Bartter)
03/2006
1Deafness (Deaf Mutism)
03/2006
1Rhinosinusitis
01/2005
1Cystic Fibrosis (Mucoviscidosis)
01/2005
1Acquired Immunodeficiency Syndrome (AIDS)
01/2005
1Dehydration (Water Stress)
01/2005
1Mucocele
01/2005
1Allergic Fungal Sinusitis
01/2005
1Cerebrospinal Fluid Leak
01/2005
1Atrophy
03/2003
1Necrosis
12/2002
1Edema (Dropsy)
10/2002

Drug/Important Bio-Agent (IBA)

2Reactive Oxygen Species (Oxygen Radicals)IBA
01/2021 - 01/2013
2Pharmaceutical PreparationsIBA
01/2021 - 12/2017
2DNA (Deoxyribonucleic Acid)IBA
12/2013 - 01/2013
2ResveratrolIBA
12/2013 - 01/2013
1AntioxidantsIBA
01/2021
1Epithelial Cell Adhesion MoleculeIBA
01/2019
1CytokinesIBA
12/2018
1Cyclin-Dependent Kinases (cdk Proteins)IBA
12/2018
1RNA-Binding Proteins (RNA-Binding Protein)IBA
01/2018
1Biological ProductsIBA
12/2017
1triptolideIBA
12/2017
1MicroRNAs (MicroRNA)IBA
09/2017
1Mechanistic Target of Rapamycin Complex 1IBA
01/2015
1MTOR InhibitorsIBA
01/2015
1(5- (2,4- bis((3S)- 3- methylmorpholin- 4- yl)pyrido(2,3- d)pyrimidin- 7- yl)- 2- methoxyphenyl)methanolIBA
01/2015
1TOR Serine-Threonine KinasesIBA
01/2015
1Cysteine (L-Cysteine)FDA Link
12/2013
1GalactosidasesIBA
12/2013
1nutlin 3IBA
08/2013
1Caspase 3 (Caspase-3)IBA
01/2013
1NF-kappa B (NF-kB)IBA
03/2006
1SaltsIBA
03/2006
1Protein Isoforms (Isoforms)IBA
03/2006
1Phospholipids (Phosphatides)FDA LinkGeneric
01/2005
1hexacyanoferrate II (ferrocyanide)IBA
01/2005
1thiocarbohydrazideIBA
01/2005
1Oxygen (Dioxygen)IBA
01/2005
1Osmium TetroxideIBA
01/2005
1Surface-Active Agents (Surfactants)IBA
01/2005
1MucinsIBA
01/2005
1Cell Surface ReceptorsIBA
03/2003
1Dystroglycans (Dystroglycan)IBA
03/2003
1Laminin (Merosin)IBA
12/2002
1Adenosine Triphosphatases (ATPase)IBA
10/2002

Therapy/Procedure

4Radiotherapy
09/2017 - 01/2006
3Therapeutics
01/2021 - 12/2017
2Drug Therapy (Chemotherapy)
12/2013 - 01/2006
1Immunotherapy
12/2018
1Transplantation
06/2008